GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 135 filers reported holding GOSSAMER BIO INC in Q4 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,665,955 | +490.8% | 6,803,500 | +5836.3% | 0.04% | +245.5% |
| Q2 2022 | $959,000 | -32.9% | 114,608 | -30.4% | 0.01% | -31.2% |
| Q1 2022 | $1,429,000 | -5.3% | 164,608 | +37.1% | 0.02% | -15.8% |
| Q3 2021 | $1,509,000 | -75.9% | 120,066 | -84.4% | 0.02% | -73.6% |
| Q2 2021 | $6,253,000 | -6.1% | 770,066 | +6.9% | 0.07% | -16.3% |
| Q1 2021 | $6,661,000 | +28.1% | 720,066 | +33.9% | 0.09% | +17.8% |
| Q4 2020 | $5,199,000 | -64.3% | 537,640 | -54.2% | 0.07% | -67.0% |
| Q3 2020 | $14,561,000 | -25.1% | 1,173,301 | -21.5% | 0.22% | -25.1% |
| Q2 2020 | $19,430,000 | +301.4% | 1,494,622 | +213.4% | 0.30% | +207.3% |
| Q1 2020 | $4,840,000 | -18.1% | 476,838 | +26.2% | 0.10% | +23.1% |
| Q4 2019 | $5,907,000 | +1723.1% | 377,936 | +1861.0% | 0.08% | +1460.0% |
| Q3 2019 | $324,000 | -85.7% | 19,273 | -81.1% | 0.01% | -82.8% |
| Q2 2019 | $2,259,000 | -31.6% | 101,864 | -33.2% | 0.03% | -34.1% |
| Q1 2019 | $3,304,000 | – | 152,483 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
| Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
| Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
| Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
| Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
| HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
| Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
| Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
| ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
| EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |